Bradley P. Smith

Brad Smith is a partner in the New York office of Gibson Dunn. He plays a leading role in high-stakes antitrust matters, offering strategic counsel on both merger-related and standalone antitrust issues. Brad is especially noted for his deep expertise in Hart-Scott-Rodino Act pre-merger notification requirements. He has advised clients across sectors including technology, life sciences, finance, transportation, and industrial clients, with completed transactions totaling over $500 billion in value.

Throughout his career, Brad’s antitrust work has included some of the largest and most high-profile matters on record: United States v. Microsoft (1998-2004), InBev’s $52 billion acquisition of Anheuser-Busch (2008), Bayer’s $66 billion acquisition of Monsanto (2016-2018), and Pfizer’s $43 billion acquisition of Seagen (2023).

Prior to joining Gibson Dunn, Brad spent 28 years at another major international law firm. A sample of Brad’s antitrust litigation and merger clearance representation from that time includes advising:

• Bayer AG in antitrust matters before the U.S. Department of Justice and as global coordinating counsel relating to the $66 billion acquisition of Monsanto and the accompanying $9 billion divestiture to BASF
• Microsoft Corporation in the landmark antitrust action by the U.S. Department of Justice and 19 states and the District of Columbia between 1998 and 2004
• Diageo plc in connection with its $335 million acquisition of Aviation gin
• Unisys Corp. in connection with the $1.2 billion sale of its U.S. Federal contracts business to Science Applications International Corp.
• Tenaris S.A. in connection with its $1.2 billion acquisition of IPSCO Tubulars Inc.
• Diageo plc in connection with its $550 million sale of a portfolio of spirits brands to Sazerac
• Seattle Genetics concerning its $614 million acquisition of Cascadian Therapeutics
• INC Research Holdings, Inc. in connection with its $7.4 billion merger with inVentiv Health, Inc.
• Navistar International Corp. concerning its $256 million alliance with TRATON (formerly Volkswagen Truck & Bus)
• Terumo Corporation in antitrust matters before the Federal Trade Commission relating to its $1.12 billion acquisition of vascular access and closure devices from Abbott and St. Jude Medical
• Alcatel-Lucent in relation to its $16.9 billion combination with Nokia Corp.
• Global pharmaceutical companies in antitrust matters relating to multiple transactions collectively valued at $13.5 billion
• ZF Friedrichshafen AG in antitrust matters before the Federal Trade Commission relating to its $12.4 billion acquisition of TRW Automotive

Brad received his law degree in 1997 from Yale Law School. He earned a C.E.P. from Institut d’Études Politiques de Paris (Sciences Po) in 1994 and a Bachelor of Arts degree from Rice University in 1993.

Brad is admitted to practice in the District of Columbia and New York.

Capabilities

• Antitrust and Competition
• Class Actions
• Mergers and Acquisitions
• Private Equity

Credentials

Education:

• Yale University - 1997 Law Degree
• Institut d’Études Politiques (Sciences Po) - 1994 Certificat d’Etudes Politiques
• Rice University - 1993 Bachelor of Arts

Admissions:

• District of Columbia Bar
• New York Bar